Relapsed or Refractory Acute Myeloid Leukemia

People with relapsed or refractory acute myeloid leukemia are asked to participate in a research study being conducted by the Montefiore Medical Center.

You may be eligible to participate in this study if you:

• Are at least ≥12 years of age
• Have confirmed diagnosis of primary or secondary Acute Myeloid Leukemia

You may not participate in this study if you:

• Have a history of an active or chronic autoimmune condition, requiring therapy
• Have second primary malignancy that requires active therapy
• Have an evidence of active central nervous system leukemia
• Have previously treatment with an anti-CD123-directed agent
• Have previously treated with any other investigational agent for 21 days or 5 half-lives
• Are known to be positive for human immunodeficiency virus (HIV), Hepatitis B or C
• Are pregnant, breast feeding or planning to become pregnant

Contact Information
Vladimir Bonhomme, Study Coordinator
Phone: (718) 920-4321
Email: VBONHOMME@MONTEFIORE.ORG

22-06-693